Sign In
Buy ELVN
Enliven Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -92.25. In total, the insiders bought 1.38M and sold 1.71M ELVN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-92.25 |
| ● Buy | 1.38M shares |
| ● Sell | 1.71M shares |
|
46% Buy Activity
Weak Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Feb 12, 2026 Buy |
Ballal Rahul D. Director |
17 126 Value: $465.1K |
||
|
Feb 12, 2026 Buy |
Gupta Rishi Director |
1 580 Value: $42.9K |
||
|
Feb 12, 2026 Buy |
Gupta Rishi Director |
33 989 Value: $923.1K |
||
|
Feb 12, 2026 Buy |
Kunkel Lori Anne Director |
17 126 Value: $465.1K |
||
|
Feb 12, 2026 Buy |
Heyman Richard A. Director |
19 234 Value: $522.4K |
||
|
Feb 12, 2026 Buy |
Garland J. Scott Director |
1 427 Value: $38.8K |
||
|
Feb 12, 2026 Buy |
Derynck Mika K Director |
17 126 Value: $465.1K |
||
|
Feb 12, 2026 Buy |
Bauer Jake Director |
17 126 Value: $465.1K |
||
|
Feb 12, 2026 Buy |
Lyssikatos Joseph P Chief Scientific Officer |
112 500 Value: $3.06M |
||
|
Feb 12, 2026 Buy |
Lyssikatos Joseph P Chief Scientific Officer |
18 750 Value: $509.3K |
||
|
Feb 12, 2026 Buy |
Collins Helen Louise Chief Medical Officer |
150 000 Value: $4.07M |
||
|
Feb 12, 2026 Buy |
Collins Helen Louise Chief Medical Officer |
25 000 Value: $679.0K |
||
|
Feb 06, 2026 Sell |
Lyssikatos Joseph P Chief Scientific Officer |
5 000 Value: $145.2K |
||
|
Jan 20, 2026 Sell |
Heyman Richard A. Director |
512 Value: $13.5K |
||
|
Jan 20, 2026 Sell |
Lyssikatos Joseph P Chief Scientific Officer |
5 491 Value: $144.8K |
||
|
Jan 20, 2026 Sell |
Lyssikatos Joseph P Chief Scientific Officer |
14 509 Value: $390.3K |
||
|
Jan 20, 2026 Sell |
Heyman Richard A. Director |
718 Value: $19.4K |
||
|
Jan 09, 2026 Sell |
Patel Anish Chief Operating Officer |
48 057 Value: $1.34M |
||
|
Jan 09, 2026 Sell |
Patel Anish Chief Operating Officer |
243 Value: $7K |
||
|
Jan 09, 2026 Sell |
Lyssikatos Joseph P Chief Scientific Officer |
50 000 Value: $1.46M |
||
|
Jan 09, 2026 Sell |
Lyssikatos Joseph P Chief Scientific Officer |
41 198 Value: $1.03M |
||
|
Jan 08, 2026 Sell |
Heyman Richard A. Director |
1 620 Value: $40.5K |
||
|
Jan 08, 2026 Sell |
Lyssikatos Joseph P Chief Scientific Officer |
33 802 Value: $842.5K |
||
|
Jan 08, 2026 Sell |
Lyssikatos Joseph P Chief Scientific Officer |
7 500 Value: $151.0K |
||
|
Jan 08, 2026 Sell |
Heyman Richard A. Director |
8 015 Value: $200.7K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
